Tag: FDA bioequivalence
FDA Bioequivalence Standards for NTI Drugs: What You Need to Know
The FDA enforces stricter bioequivalence standards for narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and digoxin. Learn how 90-111% limits, replicate studies, and tighter quality controls ensure patient safety with generic versions.
DetailRelated Posts
